Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

The Positive Impact of CFTR Modulators: a Year-Over-Year Comparison

December 22, 2020

Current CFTR modulator usage increased from nearly half of respondents in 2019, when three modulators were approved, to 68% in 2020.

Migraine Patient-Reported Survey Data

December 16, 2020

New Health Union survey data show patients experience a very high number of symptoms and triggers, reinforcing that migraine is "more than just a headache."

Inflammatory Bowel Disease Patient-Reported Survey Data

December 11, 2020

New survey data from Health Union reveals that half of respondents living with inflammatory bowel disease experience symptoms 15+ days per month.

HIV Patient-Reported Survey Data

December 7, 2020

New survey data shows 90% of people living with HIV feel controlled on their current treatment plan, but continue to struggle with great challenges.

Alzheimer’s Disease Patient-Reported Survey Data | 2020

October 6, 2020

Only 11% of people living with Alzheimer’s disease feel controlled on their current treatment plan, according to Health Union patient-reported survey data.

COPD Patient-Reported Survey Data | 2020

September 23, 2020

44% of people living with COPD who experience pain consider themselves as having chronic pain, according to new Health Union survey data.

Multiple Sclerosis Patient-Reported Survey Data | 2020

September 10, 2020

71% of people living with multiple sclerosis currently use a DMT but many live with pain and emotional grief, according to new Health Union survey data.

Rheumatoid Arthritis Patient-Reported Survey Data | 2020

August 27, 2020

Only 16% of people living with rheumatoid arthritis feel controlled on their current treatment plan, according to new Health Union survey data.

Healthcare Industry Thought Leadership

Contact